(Q37725468)

22 August 2017

1 reference

title

PPARgamma activation: a potential treatment for pulmonary hypertension (English)

1 reference

22 August 2017

arterial hypertension

0 references

author name string

Georg Hansmann

series ordinal

1

1 reference

PubMed ID

20371457

22 August 2017

Roham T Zamanian

series ordinal

2

1 reference

PubMed ID

20371457

22 August 2017

language of work or name

English

0 references

publication date

1 December 2009

1 reference

Science Translational Medicine

22 August 2017

1 reference

22 August 2017

1

1 reference

22 August 2017

12

1 reference

22 August 2017

12ps14

1 reference

Inflammation, growth factors, and pulmonary vascular remodeling

22 August 2017

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000267

Cellular and molecular basis of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000267

Genetics and genomics of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000267

An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000267

Insulin resistance in pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000267

Updated clinical classification of pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000267

Therapeutic potential of RhoA/Rho kinase inhibitors in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000267

Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000267

Gene expression patterns in the lungs of patients with primary pulmonary hypertension: a gene microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000267

Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Expression Is Decreased in Pulmonary Hypertension and Affects Endothelial Cell Growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000267

Peroxisome proliferator-activated receptor gamma ligands inhibit retinoblastoma phosphorylation and G1--> S transition in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000267

Activation of peroxisome proliferator-activated receptor gamma suppresses telomerase activity in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000267

Adiponectin deficiency: a model of pulmonary hypertension associated with pulmonary vascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000267

Adiponectin deficiency increases allergic airway inflammation and pulmonary vascular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000267

LRP: role in vascular wall integrity and protection from atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000267

Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000267

15-Deoxy-prostaglandin J(2) inhibits PDGF-A and -B chain expression in human vascular endothelial cells independent of PPAR gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000267

Adipocyte low density lipoprotein receptor-related protein gene expression and function is regulated by peroxisome proliferator-activated receptor gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000267

Tie2-mediated loss of peroxisome proliferator-activated receptor-gamma in mice causes PDGF receptor-beta-dependent pulmonary arterial muscularization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000267

Adiponectin acts as an endogenous antithrombotic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000267

"Vasocrine" signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000267

Asymmetrical dimethylarginine in idiopathic pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000267

Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000267

C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000267

Vascular inflammation is negatively autoregulated by interaction between CCAAT/enhancer-binding protein-delta and peroxisome proliferator-activated receptor-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000267

New mechanism of rosiglitazone to reduce neointimal hyperplasia: activation of glycogen synthase kinase-3beta followed by inhibition of MMP-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000267

A functional single-nucleotide polymorphism in the TRPC6 gene promoter associated with idiopathic pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000267

Peroxisome proliferator-activated receptor gamma ligands inhibit Rho/Rho kinase pathway by inducing protein tyrosine phosphatase SHP-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000267

10.1126/SCITRANSLMED.3000267

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20371457